|
Abnormal behavior
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Physiological stress measures were assessed using diurnal salivary alpha-amylase (sAA) and salivary cortisol, nail cortisol and parasympathetic activation (PNS) by overnight heart rate variability, and body composition (body mass index, skinfold thickness) and behavior problems (using the Strengths and Difficulties Questionnaire) in 324 children aged 2-6 years of the SPLASHY study.
|
30270564 |
2018 |
|
Adenocarcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
The possibility of HSGA should be considered when an adenocarcinoma producing human salivary alpha-amylase is diagnosed away from sites where major and minor salivary glands normally are found.
|
9258723 |
1997 |
|
Adenocarcinoma of lung (disorder)
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The AMY1 gene (salivary type) was exclusively and highly expressed in the salivary glands and the amylase-producing lung adenocarcinomas.
|
7507116 |
1994 |
|
Agitation
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Results showed that CRH administration increased plasma noradrenaline and cortisol concentrations, sAA activity, heart rate, as well as self-reported side effects (i.e. flushing in the facial area, heart rate changes, giddiness, malaise and restlessness) and stress perception, while plasma adrenaline levels remained unaffected.
|
28472693 |
2017 |
|
Allergic rhinitis (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
Similar sAA secretion rate was observed between the two groups (312.8 ± 124.8 (Healthy) vs. 347.9 ± 114.0 (AR) μg/min; p = 0.2444).
|
30579062 |
2019 |
|
Anorexia Nervosa
|
0.010 |
Biomarker
|
disease |
BEFREE |
This study investigated a possible correlation between opiorphin and stress/immune biomarkers, cortisol, salivary alpha-amylase (sAA) and secretory immunoglobulin A (sIgA), in saliva of patients with restrictive-type AN.
|
30880537 |
2019 |
|
Anxiety
|
0.050 |
Biomarker
|
disease |
BEFREE |
The change of sAA after stroop test in GAD patients can predict the severity of anxiety, but subjective psychological perception can not.
|
31726179 |
2020 |
|
Anxiety
|
0.050 |
Biomarker
|
disease |
BEFREE |
<b>Methods:</b> Salivary α-amylase (sAA), galvanic skin response (GSR) and anxiety were assessed over a 2-h operating flight.
|
29867525 |
2018 |
|
Anxiety
|
0.050 |
Biomarker
|
disease |
BEFREE |
We examined physiological stress responses (cortisol and salivary alpha-amylase [sAA]), negative emotional stress responses (anxiety and self-conscious emotions), and post-task ruminative thoughts.
|
31497984 |
2019 |
|
Anxiety
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
The following outcomes will be recorded: completion of dental treatment, anxiety scores at baseline and after treatment using Frankl rating behavior scale and physiological anxiety related changes will be recorded using salivary Alpha Amylase and Cortisol levels.
|
31464945 |
2019 |
|
Anxiety
|
0.050 |
Biomarker
|
disease |
BEFREE |
We examined physiological stress responses (cortisol and salivary alpha-amylase [sAA]), negative emotional stress responses (anxiety and self-conscious emotions), and post-task ruminative thoughts.
|
30265076 |
2019 |
|
Anxiety Disorders
|
0.050 |
Biomarker
|
group |
BEFREE |
The change of sAA after stroop test in GAD patients can predict the severity of anxiety, but subjective psychological perception can not.
|
31726179 |
2020 |
|
Anxiety Disorders
|
0.050 |
Biomarker
|
group |
BEFREE |
We examined physiological stress responses (cortisol and salivary alpha-amylase [sAA]), negative emotional stress responses (anxiety and self-conscious emotions), and post-task ruminative thoughts.
|
30265076 |
2019 |
|
Anxiety Disorders
|
0.050 |
Biomarker
|
group |
BEFREE |
We examined physiological stress responses (cortisol and salivary alpha-amylase [sAA]), negative emotional stress responses (anxiety and self-conscious emotions), and post-task ruminative thoughts.
|
31497984 |
2019 |
|
Anxiety Disorders
|
0.050 |
AlteredExpression
|
group |
BEFREE |
The following outcomes will be recorded: completion of dental treatment, anxiety scores at baseline and after treatment using Frankl rating behavior scale and physiological anxiety related changes will be recorded using salivary Alpha Amylase and Cortisol levels.
|
31464945 |
2019 |
|
Anxiety Disorders
|
0.050 |
Biomarker
|
group |
BEFREE |
<b>Methods:</b> Salivary α-amylase (sAA), galvanic skin response (GSR) and anxiety were assessed over a 2-h operating flight.
|
29867525 |
2018 |
|
Anxiety neurosis (finding)
|
0.020 |
Biomarker
|
disease |
BEFREE |
No mediating roles of salivary alpha-amylase and anxiety state in the cGxE effect were found.
|
30192917 |
2019 |
|
Anxiety neurosis (finding)
|
0.020 |
Biomarker
|
disease |
BEFREE |
Immediately before and after a mindfulness session, participants completed questionnaires to assess the short-term effects on mood and state anxiety and provided saliva samples to assess salivary alpha amylase (sAA) concentrations.
|
30395806 |
2019 |
|
Anxiety state
|
0.020 |
Biomarker
|
disease |
BEFREE |
Immediately before and after a mindfulness session, participants completed questionnaires to assess the short-term effects on mood and state anxiety and provided saliva samples to assess salivary alpha amylase (sAA) concentrations.
|
30395806 |
2019 |
|
Anxiety state
|
0.020 |
Biomarker
|
disease |
BEFREE |
No mediating roles of salivary alpha-amylase and anxiety state in the cGxE effect were found.
|
30192917 |
2019 |
|
Anxiety symptoms
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
This study aimed to evaluate whether the salivary alpha-amylase (sAA), cortisol levels, and anxiety symptoms differ between children with and without TMD.
|
29019550 |
2017 |
|
Autism Spectrum Disorders
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Not only do these results confirm the stress-reducing nature of two types of multisensory therapy, but they support the use of sAA as a potential tool for evaluating stress levels in individuals with intellectual disability and autism spectrum disorder, providing an important physiological lens that may guide strategies in clinical and non-clinical care for individuals with disabilities.
|
29159888 |
2018 |
|
Autistic Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Salivary α-amylase as a marker of stress reduction in individuals with intellectual disability and autism in response to occupational and music therapy.
|
29159888 |
2018 |
|
Bedwetting
|
0.010 |
Biomarker
|
disease |
BEFREE |
T&A has a favorable therapeutic effect on NE and may decrease SNA in children with OSAS. sAA might be associated with instability of ANS by OSAS and have a consistent relationship with the apnea-hypopnea index.Our studying aims had been met.
|
27876406 |
2017 |
|
Caffeine related disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
In this follow-up article, the effects of strategic caffeine administration on the previously reported diurnal profiles of sAA and performance, and the association between sAA and neurobehavioural performance were investigated.
|
29402402 |
2019 |